| Literature DB >> 21187905 |
Marco Pedicini1, Fredrik Barrenäs, Trevor Clancy, Filippo Castiglione, Eivind Hovig, Kartiek Kanduri, Daniele Santoni, Mikael Benson.
Abstract
Two T helper (Th) cell subsets, namely Th1 and Th2 cells, play an important role in inflammatory diseases. The two subsets are thought to counter-regulate each other, and alterations in their balance result in different diseases. This paradigm has been challenged by recent clinical and experimental data. Because of the large number of genes involved in regulating Th1 and Th2 cells, assessment of this paradigm by modeling or experiments is difficult. Novel algorithms based on formal methods now permit the analysis of large gene regulatory networks. By combining these algorithms with in silico knockouts and gene expression microarray data from human T cells, we examined if the results were compatible with a counter-regulatory role of Th1 and Th2 cells. We constructed a directed network model of genes regulating Th1 and Th2 cells through text mining and manual curation. We identified four attractors in the network, three of which included genes that corresponded to Th0, Th1 and Th2 cells. The fourth attractor contained a mixture of Th1 and Th2 genes. We found that neither in silico knockouts of the Th1 and Th2 attractor genes nor gene expression microarray data from patients with immunological disorders and healthy subjects supported a counter-regulatory role of Th1 and Th2 cells. By combining network modeling with transcriptomic data analysis and in silico knockouts, we have devised a practical way to help unravel complex regulatory network topology and to increase our understanding of how network actions may differ in health and disease.Entities:
Mesh:
Year: 2010 PMID: 21187905 PMCID: PMC3002992 DOI: 10.1371/journal.pcbi.1001032
Source DB: PubMed Journal: PLoS Comput Biol ISSN: 1553-734X Impact factor: 4.475
Figure 1Systemic view of the gene regulatory network model including relevant genes or transcription factors for Th1 Th2 cell differentiation.
Black edges depict positive regulation; red edges negative regulations.
The attractors of the boolean network modeling Th1/Th2 differentiation.
| Attractor | Active genes |
| Th0 | None |
| Th1 | IFN- |
| Th2 | GATA3, IL-13, IL-4, IL-4R, IL-5, IRF4, JAK1, JAK3, MAF, |
| NFAT and STAT6 | |
| ThX |
|
|
| |
|
|
ThX is the non-Th1-nor-Th2 attractor, consisting of a cycle composed by the three states , and .
Number of attractors in knock-out networks.
| Temporary Stimulation | Sustained Stimulation | |||||
| knock-out gene | attractors | (static/dynamical) | max | attractors | (static/dynamical) | max |
| COT | 4 | (3/1) | 3 | 1186 | (898/288) | 3 |
| GATA3 | 3 | (3/0) | 1 | 322 | (322/0) | 1 |
| IKBKB | 4 | (3/1) | 3 | 594 | (450/144) | 3 |
| IRAK | 4 | (3/1) | 3 | 612 | (452/160) | 3 |
| IRF4 | 9 | (3/6) | 5 | 604 | (450/154) | 5 |
| ITK | 4 | (3/1) | 3 | 1188 | (900/288) | 3 |
| JAK1 | 4 | (3/1) | 3 | 594 | (450/144) | 3 |
| JAK3 | 3 | (3/0) | 1 | 560 | (432/128) | 2 |
| LCK | 4 | (3/1) | 3 | 1187 | (899/288) | 3 |
| MAF | 4 | (3/1) | 3 | 594 | (450/144) | 3 |
| NFAT | 9 | (3/6) | 5 | 604 | (452/152) | 5 |
| NFKB | 4 | (3/1) | 3 | 594 | (450/144) | 3 |
| NIK | 4 | (3/1) | 3 | 1186 | (898/288) | 3 |
| PI3K | 4 | (3/1) | 3 | 1186 | (898/288) | 3 |
| PLCPG | 4 | (3/1) | 3 | 596 | (452/144) | 3 |
| SHP1 | 4 | (3/1) | 3 | 594 | (450/144) | 3 |
| SLP76 | 4 | (3/1) | 3 | 594 | (450/144) | 3 |
| SOCS1 | 8 | (5/3) | 3 | 978 | (594/384) | 3 |
| STAT1 | 7 | (3/4) | 6 | 1154 | (482/672) | 7 |
| STAT4 | 4 | (3/1) | 3 | 612 | (452/160) | 3 |
| STAT6 | 6 | (3/3) | 3 | 1664 | (1088/576) | 3 |
| TBET | 7 | (3/4) | 6 | 358 | (322/36) | 6 |
| VAV1 | 4 | (3/1) | 3 | 595 | (451/144) | 3 |
| ZAP70 | 4 | (3/1) | 3 | 1186 | (898/288) | 3 |
Number of attractors for the sustained and temporary stimulation; we give also the number of attractors which are of length one (static equilibrium) or of length greater than (dynamical equilibrium); moreover, we indicate the maximal length of attractors.
Figure 2Number of attractors as the result of in silico knockout experiments, in the temporary stimulation activation modality.
Stacked bars represent the percentage of attractors expressing combinations of IL-4 and/or IFN-.
Figure 3Number of attractors as the result of in silico knockout experiments, in the persisting stimulation activation modality.
Stacked bars represent the percentage of attractors expressing combinations of IL-4 and/or IFN-.
Results of Pearson's correlation test of inhibitory gene pairs.
| Gene Pair |
| correlation |
| GATA3 - TBET |
|
|
| SHP1 - JAK1 |
|
|
| IL-4R - IL18R |
|
|
| SOCS1 - IL-4R |
|
|
| SOCS1 - JAK3 |
|
|
| STAT6 - STAT4 |
|
|
| IFN- |
|
|
Specification rules for activation/inihibition links of the network in Figure 1.
| IRF4, NFAT, MAF, GATA3 |
| IL-13 |
| IRF4, NFAT, MAF, GATA3 |
| IL-5 |
| IFN- |
| TBET |
| IL-7R, TBET, STAT4,STAT1,IRAK |
| IFN- |
| STAT6 |
| MAF |
| STAT6, -TBET |
| GATA3 |
| IL-7 |
| IL-7R |
| IL-18, -IL-4R |
| IL-18R |
| IL18R |
| IRAK |
| IFN- |
| STAT1 |
| IFN- |
| IFN- |
| IFN- |
| IFN- |
| IL-4, -SOCS1 |
| IL-4R |
| IRF4, NFAT, MAF, GATA3 |
| IL-4 |
| CD80 |
| CTLA4 |
| CTLA4 |
| SHP1 |
| CD45, CD4 |
| LCK |
| TCR, CD3, -SHP1,LCK |
| ZAP70 |
| ZAP70 |
| SLP76 |
| LCK |
| VAV1 |
| CD28, VAV1, SLP76 |
| ITK |
| ITK |
| PLCPG |
| ANTIGEN |
| CD4 |
| ANTIGEN |
| TCR |
| ANTIGEN |
| CD3 |
| ANTIGEN |
| CD45 |
| TNFSF4 |
| TNFRSF4 |
| -IFN- |
| NFKB |
| STAT6, NFKB |
| IRF4 |
| CD28, TNFRSF4, PLCPG, IRF4 |
| NFAT |
| CD28, ICOS |
| PI3K |
| PI3K |
| AKT1 |
| AKT1 |
| COT |
| COT |
| NIK |
| NIK |
| IKBKB |
| CD86 |
| CD28 |
| IL-4R, -SHP1,-SOCS1 |
| JAK1 |
| IL-4R |
| JAK3 |
| IFN- |
| STAT6 |
| IL12R, IFN- |
| STAT4 |
| IFN- |
| SOCS1 |
| IL-12 |
| IL-12R |
| TNFSF4 |
| ICOS |
Gene expression microarray datasets downloaded from the Gene Expression Omnibus repository.
| GEO Accession Number | Disorder |
| GSE4588 | Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) |
| GSE6740 | HIV |
| GSE8835 | B cell chronic lymphocytic leukemia (CLL) |
| GSE9927 | Type I HIV (HIV-I) |
| GSE10586 | Type 1 Diabetes (T1D) |
| GSE12079 | Hypereosinophilic syndrome |
| GSE13732 | Clinically Isolated Syndrome - Multiple Sclerosis |
| GSE14317 | Adult T-cell leukemia/lymphoma (ATL) |
| GSE14924 | Acute Myeloid Leukaemia (AML) |
| GSE17354 | Adenosine deaminase (ADA) - Severe combined immunodeficiency (SCID) (Therapy treated) |